Potential new approach to treatment of chronic lung diseases

March 26, 2012

(Medical Xpress) -- Scientists at UCD have identified a potential new treatment for life-threatening complications associated with chronic obstructive lung diseases like emphysema and chronic bronchitis. Chronic obstructive lung diseases, most commonly caused by smoking, affect over 100,000 people in Ireland.

According to findings published recently in Circulation, it may be possible to target and regulate a protein that contributes to pulmonary - in the of the lung – a disabling and potentially fatal complication for patients suffering from chronic obstructive lung disease.

Conway Fellow, Professor Paul McLoughlin from UCD School of Medicine, who led the project said, “diseases such as , chronic and fibrosis of the lungs cause abnormally low levels of oxygen in the lung. When the lung is starved of oxygen, blood pressure in the arteries of the lung increases causing damage to blood vessels and making it more difficult for the heart to pump blood, leading in many cases to heart failure and premature death”.

While investigating the factors that contribute to high blood pressure in the arteries, the UCD research groups found that when oxygen levels in the lung are reduced, the body produces elevated quantities of a protein called gremlin – suggesting a link between elevated levels of gremlin and pulmonary hypertension.

Further investigations showed that mice whose genes had been mutated to reduce gremlin were protected against pulmonary hypertension, even when in a low oxygen environment similar to that found in lung disease. The heart was also protected and the damage to blood vessels in the lung was less severe.

Further research showed that gremlin was elevated in the lungs of patients with , confirming a key role for the protein in damaging the blood vessels of the lung.

“These research findings suggest the potential for additional novel treatments of patients by designing drugs that block the actions of gremlin in the lung”, said Professor McLoughlin.

Explore further: Reversing smoke-induced damage and disease in the lung

More information: Cahill et al. Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension. Circulation (2012) doi: 10.1161/​CIRCULATIONAHA.111.038125

Related Stories

Reversing smoke-induced damage and disease in the lung

October 13, 2011
By studying mice exposed to tobacco smoke for a period of months, researchers have new insight into how emphysema and chronic obstructive pulmonary disease (COPD) develops. In the October 14th issue of Cell they also report ...

Protein is potential new treatment target for adult pulmonary hypertension

October 17, 2011
A protein critical to development appears to have a grave impact on lungs exposed to smoking and air pollution, researchers report.

Dr. Larissa Shimoda to discuss mechanisms of hypoxic pulmonary hypertension

April 11, 2011
When muscles and organs are deprived of an adequate supply of oxygen--a condition called hypoxia--the body's usual responses include increased circulation and a slight drop in blood pressure in the blood vessels serving the ...

Protein could offer target to reduce lung damage from smoking-caused emphysema

May 16, 2011
An international research team has identified a lung protein that appears to play a key role in smoking-related emphysema and have crafted an antibody to block its activity, Indiana University scientists reported.

Recommended for you

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.